Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

“Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease” has been published in the journal Springer Link. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 biomarkers call.

Post
Filter